We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.52B
AUM Growth
+$1.2B
Cap. Flow
+$726M
Cap. Flow %
9.65%
Top 10 Hldgs %
19.11%
Holding
866
New
79
Increased
318
Reduced
279
Closed
56

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$75M
2
BIIB icon
Biogen
BIIB
+$70.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$60.1M
4
MRK icon
Merck
MRK
+$54.6M
5
GILD icon
Gilead Sciences
GILD
+$33.1M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$19.1M
2
IRBT
iRobot
IRBT
+$15.5M
3
DGX icon
Quest Diagnostics
DGX
+$15.4M
4
CL icon
Colgate-Palmolive
CL
+$14.8M
5
PM icon
Philip Morris
PM
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33.26%
2 Technology 16.05%
3 Financials 11.26%
4 Consumer Discretionary 7.98%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MAT icon
651
Mattel
MAT
$4.24B
$717K 0.01%
45,661
-23,463
-34% -$376K
ECL icon
652
Ecolab
ECL
$76.3B
$716K 0.01%
4,564
-19,007
-81% -$2.82M
FMC icon
653
FMC
FMC
$1.41B
$706K 0.01%
9,337
-16,496
-64% -$1.24M
OR icon
654
OR Royalties Inc
OR
$5.45B
$697K 0.01%
91,914
THS
655
DELISTED
Treehouse Foods
THS
$694K 0.01%
14,500
IFN
656
Aberdeen India Fund
IFN
$490M
$664K 0.01%
30,000
-10,000
-25% -$246K
HELE icon
657
Helen of Troy
HELE
$669M
$655K 0.01%
5,000
CAJ
658
DELISTED
Canon, Inc.
CAJ
$649K 0.01%
20,507
+13
+0.1% +$412
MXIM
659
DELISTED
Maxim Integrated Products
MXIM
$647K 0.01%
+11,469
New +$692K
RDHL
660
Redhill Biopharma
RDHL
$4.2M
$629K 0.01%
71
GIL icon
661
Gildan
GIL
$9.37B
$626K 0.01%
20,604
+20,573
+66,365% +$598K
RDY icon
662
Dr. Reddy's Laboratories
RDY
$9.8B
$623K 0.01%
+90,000
New +$601K
AKBA icon
663
Akebia Therapeutics
AKBA
$341M
$618K 0.01%
+70,000
New +$626K
MAN icon
664
ManpowerGroup
MAN
$2.45B
$617K 0.01%
7,180
-2,640
-27% -$235K
ENR icon
665
Energizer
ENR
$1.45B
$614K 0.01%
10,477
-355
-3% -$22.3K
LMNX
666
DELISTED
Luminex Corp
LMNX
$606K 0.01%
20,000
-10,000
-33% -$300K
CGNX icon
667
Cognex
CGNX
$10.1B
$596K 0.01%
10,683
-387
-3% -$19.8K
DECK icon
668
Deckers Outdoor
DECK
$13.7B
$593K 0.01%
30,000
LUMO
669
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$593K 0.01%
27,556
-5,000
-15% -$152K
OHI icon
670
Omega Healthcare
OHI
$15.3B
$590K 0.01%
18,000
LDOS icon
671
Leidos
LDOS
$14.4B
$588K 0.01%
8,496
-369
-4% -$25.1K
AFG icon
672
American Financial Group
AFG
$12B
$555K 0.01%
5,000
HAS icon
673
Hasbro
HAS
$12.6B
$553K 0.01%
5,260
-14,175
-73% -$1.42M
IMO icon
674
Imperial Oil
IMO
$60.7B
$549K 0.01%
16,986
-16,477
-49% -$528K
TRIL
675
DELISTED
Trillium Therapeutics Inc.
TRIL
$538K 0.01%
94,000

Similar funds

Candriam SCA's Q3 2018 Portfolio in Review

As of Q3 2018, Candriam SCA held 866 positions worth $7.52B, up 19% from $6.32B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA deployed $726M of net new capital in Q3 2018, opening 79 new positions and adding to 318 existing holdings. Its largest new stake was Varonis Systems: 541,092 shares worth $13.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.1M trimmed.

  • Candriam SCA's largest Q3 2018 buy was Varonis Systems: 541,092 shares worth $13.2M.
  • Candriam SCA added most to Amgen in Q3 2018, an estimated $75M increase.
  • Candriam SCA's biggest Q3 2018 reduction was Advanced Micro Devices, cutting an estimated $19.1M.
  • Candriam SCA fully exited iRobot in Q3 2018, selling an estimated $15.5M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.52B portfolio in Q3 2018.
  • Candriam SCA opened 79 new positions and closed 56 in Q3 2018.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $7.52B.

Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.